Related references
Note: Only part of the references are listed.Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
Zhizhong Li et al.
CANCER CELL (2009)
Design and application of oncolytic HSV vectors for glioblastoma therapy
Paola Grandi et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Activation of the Oxidative Stress Pathway by HIV-1 Vpr Leads to Induction of Hypoxia-inducible Factor 1α Expression
Satish L. Deshmane et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Herpes Simplex Virus Oncolytic Therapy for Pediatric Malignancies
Gregory K. Friedman et al.
MOLECULAR THERAPY (2009)
Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1α to induce vascular endothelial growth factor expression
Young C. Shin et al.
CANCER RESEARCH (2008)
The role of hypoxia-inducible factors in tumorigenesis
E. B. Rankin et al.
CELL DEATH AND DIFFERENTIATION (2008)
Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61
Kazuhiko Kurozumi et al.
MOLECULAR THERAPY (2008)
An oncolytic mutant of herpes simplex virus type-1 in which replication is governed by a promoter/enhancer of human papillomavirus type-16
C. Griffith et al.
CANCER GENE THERAPY (2007)
Evaluation of HIF-1 inhibitors as anticancer agents
Gregg L. Semenza
DRUG DISCOVERY TODAY (2007)
被撤回的出版物: Hepatitis C virus stabilizes hypoxia-inducible factor 1α and stimulates the synthesis of vascular endothelial growth factor (Retracted article. See vol. 94, 2020)
Md Nasimuzzaman et al.
JOURNAL OF VIROLOGY (2007)
A potential α-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1α in normoxia
Qiliang Cai et al.
JOURNAL OF VIROLOGY (2007)
Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells
Mariko Tomita et al.
BIOCHEMICAL JOURNAL (2007)
Targeted cancer gene therapy using a hypoxia inducible factor-dependent oncolytic adenovirus armed with interleukin-4
Dawn E. Post et al.
CANCER RESEARCH (2007)
Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer
Toru Hiraga et al.
CANCER RESEARCH (2007)
Hypoxia-inducible factor-1α is a key regulator of metastasis in a transgenic model of cancer initiation and progression
Debbie Liao et al.
CANCER RESEARCH (2007)
Oncolytic viruses driven by tumor-specific promoters
Jayson Hardcastle et al.
CURRENT CANCER DRUG TARGETS (2007)
Hypoxia inducible factor (HIF) function in innate immunity and infection
Annelies S. Zinkernagel et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Evidence that the immediate-early gene product ICP4 is necessary for the genome of the herpes simplex virus type 1 ICP4 deletion mutant strain d120 to circularize in infected cells
Ying-Hsiu Su et al.
JOURNAL OF VIROLOGY (2006)
Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors
Patrick A. Carroll et al.
JOURNAL OF VIROLOGY (2006)
EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1α through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells
Satoru Kondo et al.
CANCER RESEARCH (2006)
Effective treatment of tumors with strong β-catenin T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector
Toshihiko Kuroda et al.
CANCER RESEARCH (2006)
Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1α to upregulate RTA expression during hypoxia:: Latency control under low oxygen conditions
Qiliang Cai et al.
JOURNAL OF VIROLOGY (2006)
Evaluating hypoxia-inducible factor-1α as a cancer therapeutic target via inducible RNA interference in vivo
LM Li et al.
CANCER RESEARCH (2005)
Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1
R Hagglund et al.
JOURNAL OF VIROLOGY (2004)
Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors
DE Post et al.
CLINICAL CANCER RESEARCH (2004)
The carboxy-terminus of the hepatitis B virus X protein is necessary and sufficient for the activation of hypoxia-inducible factor-α
YG Yoo et al.
FEBS LETTERS (2004)
Role of hypoxia-inducible factor 1α in gastric cancer cell growth, angiogenesis, and vessel maturation
O Stoeltzing et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1α
N Wakisaka et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1α through activation of mitogen-activated protein kinase pathway
YG Yoo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The hypoxic response of tumors is dependent on their microenvironment
B Blouw et al.
CANCER CELL (2003)
A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy
DE Post et al.
ONCOGENE (2003)
Inhibition of HIF2 alpha is sufficient to suppress pVHL-defective tumor growth
K Kondo et al.
PLOS BIOLOGY (2003)
Regulation of herpes simplex virus 1 replication using tumor-associated promoters
JT Mullen et al.
ANNALS OF SURGERY (2002)
Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells
DE Post et al.
GENE THERAPY (2001)
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
KL Talks et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
